{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T04:15:42Z","timestamp":1792815342122,"version":"4.5.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T00:00:00Z","timestamp":1754265600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T00:00:00Z","timestamp":1754265600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Natural Science Foundation of Shandong Provinc"},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82102867"],"award-info":[{"award-number":["82102867"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82102867"],"award-info":[{"award-number":["82102867"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Natural Science Foundation of Shandong Provinc"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Luminal breast cancer (BC) with axillary lymph node (ALN) metastasis is typically treated with neoadjuvant chemotherapy (NAC). Theoretically, patients who achieve pathological lymph node complete response after NAC can be exempted from ALN dissection and even have the possibility of being spared axillary surgery. However, there is no effective way to preoperatively assess whether a metastatic ALN achieved pathological lymph node complete response (pLCR) after NAC. Therefore, we retrospectively collected imaging, clinical, and pathological data from two centres, built a multi-omic model to predict pLCR, and validated its accuracy and clinical applicability. We identified 12 radiomic and four clinicopathological features for model construction; the areas under the curve for training and validation cohorts were 0.853 and 0.805, respectively. Subsequently, single-cell RNA sequencing analysis was conducted on patients with different efficacy and its association with the tumour immune microenvironment was investigated. Eleven cell clusters in 14 samples from five patients were identified with differing NAC responses; comparative analysis indicated that those with poor responses had immunosuppressive features, which provided a theoretical basis for elucidating the resistance mechanism of NAC in axillary metastatic lymph nodes. The multi-omics prediction model demonstrated good performance in predicting ALN status after NAC, offering the possibility of reducing unnecessary axillary surgery.<\/jats:p>","DOI":"10.1038\/s41419-025-07877-6","type":"journal-article","created":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T16:54:03Z","timestamp":1754326443000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Multi-omics prediction of axillary treatment response and tumour microenvironment alterations in lymph node-positive luminal breast cancer"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1512-8018","authenticated-orcid":false,"given":"Teng","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zirui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongmei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianyi","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5585-704X","authenticated-orcid":false,"given":"Haibo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,4]]},"reference":[{"key":"7877_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229\u201363.","journal-title":"CA Cancer J Clin"},{"key":"7877_CR2","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1001\/jama.2017.11470","volume":"318","author":"AE Giuliano","year":"2017","unstructured":"Giuliano AE, Ballman KV, McCall L, Beitsch PD, Brennan MB, Kelemen PR, et al. Effect of axillary dissection vs no axillary dissection on 10-year overall survival among women with invasive breast cancer and sentinel node metastasis: the ACOSOG Z0011 (Alliance) randomized clinical trial. J Am Med Assoc. 2017;318:918\u201326.","journal-title":"J Am Med Assoc"},{"key":"7877_CR3","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1634\/theoncologist.2018-0228","volume":"24","author":"R Colomer","year":"2019","unstructured":"Colomer R, Saura C, S\u00e1nchez-Rovira P, Pascual T, Rubio IT, Burgu\u00e9s O, et al. Neoadjuvant management of early breast cancer: a clinical and investigational position statement. Oncologist. 2019;24:603\u201311.","journal-title":"Oncologist"},{"key":"7877_CR4","doi-asserted-by":"publisher","first-page":"691","DOI":"10.6004\/jnccn.2022.0030","volume":"20","author":"WJ Gradishar","year":"2022","unstructured":"Gradishar WJ, Moran MS, Abraham J, Aft R, Agnese D, Allison KH, et al. Breast Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Cancer Netw. 2022;20:691\u2013722.","journal-title":"J Natl Compr Cancer Netw"},{"key":"7877_CR5","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/S0140-6736(13)62422-8","volume":"384","author":"P Cortazar","year":"2014","unstructured":"Cortazar P, Zhang L, Untch M, Mehta K, Costantino JP, Wolmark N, et al. Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis. Lancet. 2014;384:164\u201372.","journal-title":"Lancet"},{"key":"7877_CR6","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1097\/SLA.0000000000002953","volume":"268","author":"OM Fayanju","year":"2018","unstructured":"Fayanju OM, Ren Y, Thomas SM, Greenup RA, Plichta JK, Rosenberger LH, et al. The clinical significance of breast-only and node-only pathologic complete response (pCR) after neoadjuvant chemotherapy (NACT): a review of 20,000 breast cancer patients in the National Cancer Data Base (NCDB)[J]. Ann Surg. 2018;268:591\u2013601.","journal-title":"Ann Surg"},{"key":"7877_CR7","doi-asserted-by":"publisher","first-page":"e210891","DOI":"10.1001\/jamasurg.2021.0891","volume":"156","author":"S Samiei","year":"2021","unstructured":"Samiei S, Simons JM, Engelen SME, Beets-Tan RGH, Classe JM, Smidt ML, et al. Axillary pathologic complete response after neoadjuvant systemic therapy by breast cancer subtype in patients with initially clinically node-positive disease: a systematic review and meta-analysis. JAMA Surg. 2021;156:e210891.","journal-title":"JAMA Surg"},{"key":"7877_CR8","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1001\/jamaoncol.2015.4935","volume":"2","author":"SS Mougalian","year":"2016","unstructured":"Mougalian SS, Hernandez M, Lei X, Lynch S, Kuerer HM, Symmans WF, et al. Ten-year outcomes of patients with breast cancer with cytologically confirmed axillary lymph node metastases and pathologic complete response after primary systemic chemotherapy. JAMA Oncol. 2016;2:508\u201316.","journal-title":"JAMA Oncol"},{"key":"7877_CR9","doi-asserted-by":"publisher","first-page":"e430","DOI":"10.1016\/S1470-2045(16)30311-4","volume":"17","author":"I Jatoi","year":"2016","unstructured":"Jatoi I, Benson JR, Toi M. De-escalation of axillary surgery in early breast cancer. Lancet Oncol. 2016;17:e430\u201341.","journal-title":"Lancet Oncol"},{"key":"7877_CR10","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1001\/jamaoncol.2023.3667","volume":"9","author":"SA KHAN","year":"2023","unstructured":"KHAN SA. Sentinel node biopsy for early breast cancer\u2014a sound for de-escalation. JAMA Oncol. 2023;9:1501\u20133.","journal-title":"JAMA Oncol"},{"key":"7877_CR11","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1097\/SLA.0000000000004356","volume":"273","author":"S Samiei","year":"2021","unstructured":"Samiei S, de Mooij CM, Lobbes MBI, Keymeulen KBMI, van Nijnatten TJA, Smidt ML. Diagnostic performance of noninvasive imaging for assessment of axillary response after neoadjuvant systemic therapy in clinically node-positive breast cancer: a systematic review and meta-analysis. Ann Surg. 2021;273:694\u2013700.","journal-title":"Ann Surg"},{"key":"7877_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00330-022-08952-8","volume":"33","author":"M Hou","year":"2023","unstructured":"Hou M, Zhou L, Sun J. Deep-learning-based 3D super-resolution MRI radiomics model: superior predictive performance in preoperative T-staging of rectal cancer. Eur Radio. 2023;33:1\u201310.","journal-title":"Eur Radio"},{"key":"7877_CR13","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s00330-023-10103-6","volume":"34","author":"B Barufaldi","year":"2024","unstructured":"Barufaldi B, Acciavatti RJ, Conant EF, Maidment ADA. Impact of super-resolution and image acquisition on the detection of calcifications in digital breast tomosynthesis. Eur Radio. 2024;34:193\u2013203.","journal-title":"Eur Radio"},{"key":"7877_CR14","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.ejca.2011.11.036","volume":"48","author":"P Lambin","year":"2012","unstructured":"Lambin P, Rios-Velazquez E, Leijenaar R, Carvalho S, van Stiphout RG, Granton P, et al. Radiomics: extracting more information from medical images using advanced feature analysis. Eur J Cancer. 2012;48:441\u20136.","journal-title":"Eur J Cancer"},{"key":"7877_CR15","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1148\/radiol.2015151169","volume":"278","author":"RJ Gillies","year":"2016","unstructured":"Gillies RJ, Kinahan PE, Hricak H. Radiomics: images are more than pictures, they are data. Radiology. 2016;278:563\u201377.","journal-title":"Radiology"},{"key":"7877_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-021-03117-5","volume":"19","author":"K Sun","year":"2021","unstructured":"Sun K, Jiao Z, Zhu H, Chai W, Yan X, Fu C, et al. Radiomics-based machine learning analysis and characterization of breast lesions with multiparametric diffusion-weighted MR[J]. J Transl Med. 2021;19:443.","journal-title":"J Transl Med"},{"key":"7877_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-15027-z","volume":"11","author":"X Zheng","year":"2020","unstructured":"Zheng X, Yao Z, Huang Y, Yu Y, Wang Y, Liu Y, et al. Deep learning radiomics can predict axillary lymph node status in early-stage breast cancer. Nat Commun. 2020;11:1236.","journal-title":"Nat Commun"},{"key":"7877_CR18","volume":"375","author":"F Conforti","year":"2021","unstructured":"Conforti F, Pala L, Sala I, Oriecuia C, De Pas T, Specchia C, et al. Evaluation of pathological complete response as surrogate endpoint in neoadjuvant randomised clinical trials of early stage breast cancer: systematic review and meta-analysis. Br Med J. 2021;375:e66381.","journal-title":"Br Med J"},{"key":"7877_CR19","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1093\/bjs\/znac217","volume":"109","author":"ML Gasparri","year":"2022","unstructured":"Gasparri ML, de Boniface J, Poortmans P, Gentilini OD, Kaidar-Person O, Banys-Paluchowski M, et al. Axillary surgery after neoadjuvant therapy in initially node-positive breast cancer: international EUBREAST survey. Br J Surg. 2022;109:857\u201363.","journal-title":"Br J Surg"},{"key":"7877_CR20","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.3390\/cancers13071539","volume":"13","author":"PK Swarnkar","year":"2021","unstructured":"Swarnkar PK, Tayeh S, Michell MJ, Mokbel K. The evolving role of marked lymph node biopsy (MLNB) and targeted axillary dissection (TAD) after neoadjuvant chemotherapy (NACT) for node-positive breast cancer: systematic review and pooled analysis. Cancers (Basel). 2021;13:1539.","journal-title":"Cancers (Basel)"},{"key":"7877_CR21","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s10549-022-06545-z","volume":"193","author":"AA van Loevezijn","year":"2022","unstructured":"van Loevezijn AA, van der Noordaa MEM, Stokkel MPM, van Werkhoven ED, Groen EJ, Loo CE, et al. Three-year follow-up of de-escalated axillary treatment after neoadjuvant systemic therapy in clinically node-positive breast cancer: the MARI-protocol. Breast Cancer Res Treat. 2022;193:37\u201348.","journal-title":"Breast Cancer Res Treat"},{"key":"7877_CR22","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1001\/jama.2013.278932","volume":"310","author":"JC Boughey","year":"2013","unstructured":"Boughey JC, Suman VJ, Mittendorf EA, Ahrendt GM, Wilke LG, Taback B, et al. Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial. J Am Med Assoc. 2013;310:1455\u201361.","journal-title":"J Am Med Assoc"},{"key":"7877_CR23","doi-asserted-by":"publisher","first-page":"18","DOI":"10.21037\/tbcr-24-31","volume":"5","author":"J Li","year":"2024","unstructured":"Li J, Hao C, Wang K, Zhang J, Chen J, Liu Y, et al. Chinese Society of Clinical Oncology (CSCO) Breast Cancer guidelines 2024[J]. Transl Breast Cancer Res. 2024;5:18.","journal-title":"Transl Breast Cancer Res"},{"key":"7877_CR24","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1055\/a-1499-8431","volume":"81","author":"M Friedrich","year":"2021","unstructured":"Friedrich M, K\u00fchn T, Janni W, M\u00fcller V, Banys-Pachulowski M, Kolberg-Liedtke C, et al. AGO recommendations for the surgical therapy of the axilla after neoadjuvant chemotherapy: 2021 update. Geburtshilfe Frauenheilkd. 2021;81:1112\u201320.","journal-title":"Geburtshilfe Frauenheilkd"},{"key":"7877_CR25","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1016\/j.ejso.2015.07.020","volume":"41","author":"TJ van Nijnatten","year":"2015","unstructured":"van Nijnatten TJ, Schipper RJ, Lobbes MB, Nelemans PJ, Beets-Tan RG, Smidt ML. The diagnostic performance of sentinel lymph node biopsy in pathologically confirmed node positive breast cancer patients after neoadjuvant systemic therapy: a systematic review and meta-analysis[J]. Eur J Surg Oncol. 2015;41:1278\u201387.","journal-title":"Eur J Surg Oncol"},{"key":"7877_CR26","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.3390\/cancers13071565","volume":"13","author":"M Banys-Paluchowski","year":"2021","unstructured":"Banys-Paluchowski M, Gasparri ML, de Boniface J, Gentilini O, Stickeler E, Hartmann S, et al. Surgical management of the axilla in clinically node-positive breast cancer patients converting to clinical node negativity through neoadjuvant chemotherapy: current status, knowledge gaps, and rationale for the EUBREAST-03 AXSANA study. Cancers (Basel). 2021;13:1565.","journal-title":"Cancers (Basel)"},{"key":"7877_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2022.101756","volume":"55","author":"T Reimer","year":"2023","unstructured":"Reimer T, Stachs A, Veselinovic K, Polata S, M\u00fcller T, K\u00fchn T, et al. Patient-reported outcomes for the Intergroup Sentinel Mamma study (INSEMA): A randomised trial with persistent impact of axillary surgery on arm and breast symptoms in patients with early breast cancer. EClinicalMedicine. 2023;55:101756.","journal-title":"EClinicalMedicine"},{"key":"7877_CR28","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1001\/jamasurg.2022.3907","volume":"157","author":"JM Simons","year":"2022","unstructured":"Simons JM, van Nijnatten TJA, van der Pol CC, van Diest PJ, Jager A, van Klaveren D, et al. Diagnostic accuracy of radioactive iodine seed placement in the axilla with sentinel lymph node biopsy after neoadjuvant chemotherapy in node-positive breast cancer. JAMA Surg. 2022;157:991\u20139.","journal-title":"JAMA Surg"},{"key":"7877_CR29","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1148\/radiol.2020191145","volume":"295","author":"A Zwanenburg","year":"2020","unstructured":"Zwanenburg A, Valli\u00e8res M, Abdalah MA, Aerts HJWL, Andrearczyk V, Apte A, et al. The image biomarker standardization initiative: standardized quantitative radiomics for high-throughput image-based phenotyping. Radiology. 2020;295:328\u201338.","journal-title":"Radiology"},{"key":"7877_CR30","doi-asserted-by":"publisher","first-page":"e2028086","DOI":"10.1001\/jamanetworkopen.2020.28086","volume":"3","author":"Y Yu","year":"2020","unstructured":"Yu Y, Tan Y, Xie C, Hu Q, Ouyang J, Chen Y, et al. Development and validation of a preoperative magnetic resonance imaging radiomics-based signature to predict axillary lymph node metastasis and disease-free survival in patients with early-stage breast cancer. JAMA Netw Open. 2020;3:e2028086.","journal-title":"JAMA Netw Open"},{"key":"7877_CR31","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1200\/JCO.21.02439","volume":"40","author":"A Pfob","year":"2022","unstructured":"Pfob A, Sidey-Gibbons C, Rauch G, Thomas B, Schaefgen B, Kuemmel S, et al. Intelligent vacuum-assisted biopsy to identify breast cancer patients with pathologic complete response (ypT0 and ypN0) after neoadjuvant systemic treatment for omission of breast and axillary surgery. J Clin Oncol. 2022;40:1903\u201315.","journal-title":"J Clin Oncol"},{"key":"7877_CR32","doi-asserted-by":"publisher","first-page":"6","DOI":"10.3390\/jimaging7060101","volume":"7","author":"P Kaur","year":"2021","unstructured":"Kaur P, Sao AK, Ahuja CK. Super resolution of magnetic resonance images. J Imaging. 2021;7:6.","journal-title":"J Imaging"},{"key":"7877_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-00898-z","volume":"11","author":"EC de Farias","year":"2021","unstructured":"de Farias EC, di Noia C, Han C, Sala E, Castelli M, Rundo L. Impact of GAN-based lesion-focused medical image super-resolution on the robustness of radiomic features. Sci Rep. 2021;11:21361.","journal-title":"Sci Rep."},{"key":"7877_CR34","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1038\/s41392-020-00449-4","volume":"6","author":"T Tang","year":"2021","unstructured":"Tang T, Huang X, Zhang G, Hong Z, Bai X, Liang T. Advantages of targeting the tumor immune microenvironment over blocking immune checkpoint in cancer immunotherapy. Signal Transduct Target Ther. 2021;6:72.","journal-title":"Signal Transduct Target Ther"},{"key":"7877_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms15081","volume":"8","author":"W Chung","year":"2017","unstructured":"Chung W, Eum HH, Lee HO, Lee KM, Lee HB, Kim KT, et al. Single-cell RNA-seq enables comprehensive tumour and immune cell profiling in primary breast cancer. Nat Commun. 2017;8:15081.","journal-title":"Nat Commun"},{"key":"7877_CR36","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1038\/s41591-018-0078-7","volume":"24","author":"P Savas","year":"2018","unstructured":"Savas P, Virassamy B, Ye C, Salim A, Mintoff CP, Caramia F, et al. Single-cell profiling of breast cancer T cells reveals a tissue-resident memory subset associated with improved prognosis. Nat Med. 2018;24:986\u201393.","journal-title":"Nat Med"},{"key":"7877_CR37","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.3390\/biomedicines9091277","volume":"9","author":"A Rotte","year":"2021","unstructured":"Rotte A, Sahasranaman S, Budha N. Targeting TIGIT for immunotherapy of cancer: update on clinical development. Biomedicines. 2021;9:1277.","journal-title":"Biomedicines"},{"key":"7877_CR38","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1182\/blood-2005-02-0817","volume":"106","author":"KS Boles","year":"2005","unstructured":"Boles KS, Barchet W, Diacovo T, Cella M, Colonna M. The tumor suppressor TSLC1\/NECL-2 triggers NK-cell and CD8+ T-cell responses through the cell-surface receptor CRTAM. Blood. 2005;106:779\u201386.","journal-title":"Blood"},{"key":"7877_CR39","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1016\/j.neuroimage.2006.01.015","volume":"31","author":"PA Yushkevich","year":"2006","unstructured":"Yushkevich PA, Piven J, Hazlett HC, Smith RG, Ho S, Gee JC, et al. User-guided 3D active contour segmentation of anatomical structures: significantly improved efficiency and reliability. Neuroimage. 2006;31:1116\u201328.","journal-title":"Neuroimage"},{"key":"7877_CR40","doi-asserted-by":"publisher","first-page":"e104","DOI":"10.1158\/0008-5472.CAN-17-0339","volume":"77","author":"JJM van Griethuysen","year":"2017","unstructured":"van Griethuysen JJM, Fedorov A, Parmar C, Hosny A, Aucoin N, Narayan V, et al. Computational radiomics system to decode the radiographic phenotype. Cancer Res. 2017;77:e104\u20137.","journal-title":"Cancer Res"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07877-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07877-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07877-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T13:58:21Z","timestamp":1757339901000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07877-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,4]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7877"],"URL":"https:\/\/doi.org\/10.1038\/s41419-025-07877-6","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,4]]},"assertion":[{"value":"1 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This retrospective study was performed in accordance with the Declaration of Helsinki and approved by the by the Affiliated Hospital of Qingdao University ethics committee (QYFY-WZLL-27822), Informed consent was obtained from all subjects.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"588"}}